The Anti-a16z? Vijay Pande’s Bet on a Tiny, AI-Native VC Firm
In this episode, Connie is joined by Vijay Pande, co-founder of VZ and former general partner at Andreessen Horowitz, to discuss why he believes AI is poised to transform healthcare and create a new generation of trillion-dollar companies. Pande explains how AI could improve drug discovery and clinical trials, why better data could move medicine beyond unreliable animal models, and how technology is giving patients more agency over their own health.
The two also discuss Pande’s decision to leave a16z and build a small, AI-native venture firm, why VZ plans to make only a handful of highly…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.